Our in vitro data shows that wild type p53 neuroblastoma cells treated with pevonedistat underwent apoptosis, arrested in G0/G1, and expressed decreased WEE1, a regulator of the G2 checkpoint in response to DNA damage. The gene discussed is TP53; the disease is neuroblastoma.